CENTOGENE Revenue and Competitors

License our Company Data API

Rostock,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

CENTOGENE's estimated annual revenue is currently $113.2M per year.(i)
CENTOGENE's estimated revenue per employee is $175,000

Employee Data

CENTOGENE has 647 Employees.(i)

CENTOGENE's People

Name	Title	Email/Phone
1 Andrin Oswald	CEO	Reveal Email/Phone
2 Volkmar Weckess...	CIO	Reveal Email/Phone
3 Kim Stratton	CEO	Reveal Email/Phone
4 Peter Bauer	Chief Medical and Genomic Officer	Reveal Email/Phone
5 Richard Stoffel...	Chief Financial Officer	Reveal Email/Phone
6 Sun Kim	Chief Strategy & IR Officer	Reveal Email/Phone
7 Florian Vogel	Chief Process Officer	Reveal Email/Phone
8 Maximilian Schm...	Chief Commercial Officer	Reveal Email/Phone
9 Michael Motz	Chief Commercial Officer - Pharmaceuticals	Reveal Email/Phone
10 Philip Lambert	Chief Scientific Officer	Reveal Email/Phone

CENTOGENE Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Mersive	$12.6M	90	-36%	$14.1M	N/A
#2 Quantum Metric	$83.2M	468	-3%	$251M	N/A
#3 Intellectyx	$14M	100	1%	N/A	N/A
#4 GitPrime	$14.6M	0	N/A	$12.5M	N/A
#5 Aunalytics	$30.3M	197	-6%	N/A	N/A
#6 250ok	$0.1M	6	-25%	$2.6M	N/A
#7 Blue Ridge	$45.1M	293	2%	N/A	N/A
#8 AnswerRocket	$4.8M	43	-7%	N/A	N/A
#9 AHEAD	$399.3M	2037	40%	N/A	N/A
#10 Arity	$44M	286	4%	N/A	N/A

Add Company

Show More Analytics Companies

What Is CENTOGENE?

CENTOGENE - transforming genetic data into medical decisions. We are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives us a unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. We focus exclusively on providing the highest quality, patient-centred service, verified by multiple international accreditations (ISO, CAP, CLIA), regular pharmaceutical audits and our outstanding short turn-around times for analysis. We believe our medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Our mutation database (CentoMDÂ®) is the world's largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. CENTOGENE is a key partner for many high-profile pharmaceutical companies who are active in the orphan drug development.

keywords:N/A

N/A

Total Funding

647

Number of Employees

$113.2M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A